| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jewell A Jessup | |
| Carlos M Ferrario | |||
| Aaron J Trask | |||
| P2860 | cites work | A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 |
| The mas oncogene encodes an angiotensin receptor | Q24298473 | ||
| Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump | Q24299365 | ||
| Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism | Q24300310 | ||
| Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins | Q24321922 | ||
| Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas | Q24680069 | ||
| ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis | Q27643059 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
| Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
| Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme | Q28216431 | ||
| ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors | Q28218830 | ||
| The mas oncogene as a neural peptide receptor: expression, regulation and mechanism of action | Q28249627 | ||
| A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury | Q28260798 | ||
| Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor | Q28573659 | ||
| Cardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy | Q79096678 | ||
| Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension | Q79214001 | ||
| Renal ACE2 expression in human kidney disease | Q80990190 | ||
| Genome-wide scan for Japanese familial intracranial aneurysms: linkage to several chromosomal regions | Q81072729 | ||
| ACE and ACE2: a tale of two enzymes | Q81320236 | ||
| Myocardial infarction increases ACE2 expression in rat and humans | Q81656120 | ||
| Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues | Q73127508 | ||
| Hypothesis: ACE2 modulates blood pressure in the mammalian organism | Q73167489 | ||
| Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system | Q73989986 | ||
| Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system | Q74132679 | ||
| Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme | Q74132686 | ||
| Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan | Q74165944 | ||
| Differential actions of renal ischemic injury on the intrarenal angiotensin system | Q74346345 | ||
| N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE | Q74423538 | ||
| Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts | Q74758710 | ||
| Converting enzyme determines plasma clearance of angiotensin-(1-7) | Q77310280 | ||
| Differential response of angiotensin peptides in the urine of hypertensive animals | Q77425675 | ||
| Angiotensin-(1-7) reduces smooth muscle growth after vascular injury | Q77945580 | ||
| Angiotensin-(1-7) in normal and preeclamptic pregnancy | Q78568866 | ||
| Slow ventricular conduction in mice heterozygous for a connexin43 null mutation | Q28591559 | ||
| Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice | Q28593966 | ||
| The renin-angiotensin system: peptides and enzymes beyond angiotensin II | Q28645960 | ||
| Angiotension-(1-7) and antihypertensive mechanisms | Q33536947 | ||
| Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide | Q33579511 | ||
| Angiotensin-(1-7): an update. | Q34019825 | ||
| The adipose tissue as a source of vasoactive factors | Q34342326 | ||
| The angiotensin-converting enzyme gene family: genomics and pharmacology | Q34586915 | ||
| Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? | Q35099121 | ||
| Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries | Q35139444 | ||
| ACE2, a new regulator of the renin-angiotensin system | Q35756519 | ||
| Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. | Q35833603 | ||
| Enhanced expression of Ang-(1-7) during pregnancy | Q35845564 | ||
| Is angiotensin II made inside or outside of the cell? | Q36062239 | ||
| Angiotensin-[1-7]: evidence for novel actions in the brain | Q36631113 | ||
| Hypertension and coronary artery disease. Can the chain be broken? | Q37103647 | ||
| Angiotensin-(1-7): a new hormone of the angiotensin system | Q37450381 | ||
| A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. | Q40853474 | ||
| Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects | Q41364638 | ||
| Counterregulatory actions of angiotensin-(1-7). | Q41607078 | ||
| Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). | Q41659395 | ||
| Evidence for a functional cardiac interaction between losartan and angiotensin-(1-7) receptors revealed by orthostatic tilting test in rats | Q42016830 | ||
| Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neurones | Q42086362 | ||
| News about ACE, or, the separate lives of "Siamese twin" domains | Q42356218 | ||
| Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). | Q42447014 | ||
| Single mutations at Asn295 and Leu305 in the cytoplasmic half of transmembrane alpha-helix domain 7 of the AT1 receptor induce promiscuous agonist specificity for angiotensin II fragments: a pseudo-constitutive activity | Q42478506 | ||
| Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2). | Q42690932 | ||
| Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7). | Q43573763 | ||
| Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells | Q43576527 | ||
| Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion | Q43744776 | ||
| Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man. | Q43777437 | ||
| Angiotensin peptides modulate bradykinin levels in the interstitium of the dog heart in vivo | Q43830188 | ||
| The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan | Q43907228 | ||
| Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation | Q43912171 | ||
| Angiotensin-(1-7) stimulates oxidative stress in rat kidney | Q44016672 | ||
| Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension | Q44034807 | ||
| Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7). | Q44201695 | ||
| Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR. | Q44249678 | ||
| Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. | Q44353743 | ||
| Angiotensin-(1-7): a novel peptide in the ovary. | Q44405108 | ||
| Characterization of angiotensin-(1–7) receptor subtype in mesenteric arteries | Q44430740 | ||
| Effects of truncated angiotensins in humans after double blockade of the renin system | Q44517333 | ||
| Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. | Q44592757 | ||
| Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors | Q44790566 | ||
| Angiotensin type-1 receptor blockade increases ACE 2 expression in the heart | Q44790573 | ||
| Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats | Q44811232 | ||
| The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules | Q45092010 | ||
| Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression | Q45115249 | ||
| Losartan increases bradykinin levels in hypertensive humans | Q45227736 | ||
| Myocardial infarction increases ACE2 expression in rat and humans. | Q45238600 | ||
| Pharmacological concentration of angiotensin-(1-7) activates NADPH oxidase after ischemia-reperfusion in rat heart through AT1 receptor stimulation. | Q45244185 | ||
| Sodium status and angiotensin-converting enzyme inhibition: effects on plasma angiotensin-(1-7) in healthy man. | Q45270252 | ||
| Identification of angiotensin converting enzyme 2 in the rodent retina. | Q46374769 | ||
| G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor | Q46421423 | ||
| Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats | Q46440284 | ||
| Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. | Q46493539 | ||
| The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension. | Q47236987 | ||
| Angiotensin-converting enzyme 2 protects from severe acute lung failure | Q47768368 | ||
| Angiotensin-(1-7) immunoreactivity in the hypothalamus of the (mRen-2d)27 transgenic rat. | Q47836966 | ||
| Converting enzyme activity and angiotensin metabolism in the dog brainstem. | Q48120667 | ||
| In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats | Q48478548 | ||
| State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle | Q48581865 | ||
| The renin-angiotensin system during acute myocardial ischemia in dogs | Q49106527 | ||
| Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. | Q50701988 | ||
| Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats. | Q51380827 | ||
| Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. | Q51528582 | ||
| No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. | Q51995128 | ||
| Enhanced Renal Immunocytochemical Expression of ANG-(1-7) and ACE2 During Pregnancy | Q57185045 | ||
| Neutral endopeptidase and angiotensin I converting enzyme insertion/deletion gene polymorphism in humans | Q57244745 | ||
| Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats | Q61965141 | ||
| Potentiation of the hypotensive effect of bradykinin by angiotensin-(1–7)-related peptides | Q62124894 | ||
| Angiotensins. A family that grows from within | Q68190280 | ||
| The mosaic theory 32 years later | Q70310776 | ||
| Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved | Q70724478 | ||
| Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats | Q70882366 | ||
| Angiotensin-(1-7) inhibits vascular smooth muscle cell growth | Q71173612 | ||
| Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension | Q71503848 | ||
| Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension | Q71688965 | ||
| Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats | Q71949723 | ||
| Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats | Q72282326 | ||
| Cardiovascular actions of angiotensin(1-7) | Q72589225 | ||
| Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide | Q73086568 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | H2281-90 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function | |
| P478 | volume | 289 |
| Q38311340 | A Review of Potential Marine-derived Hypotensive and Anti-obesity Peptides |
| Q79817382 | ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7) |
| Q45268057 | ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET. |
| Q92946509 | ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease |
| Q40310227 | ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy. |
| Q34355126 | ACE2 and diabetes: ACE of ACEs? |
| Q48491814 | ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. |
| Q35138448 | ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. |
| Q36877738 | ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. |
| Q34784864 | ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. |
| Q37806553 | ACE2: more of Ang-(1-7) or less Ang II? |
| Q37274124 | AT2 receptors: functional relevance in cardiovascular disease. |
| Q35395547 | Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats |
| Q33783689 | Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control |
| Q55465043 | Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7). |
| Q34830604 | Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. |
| Q48125284 | Altered regional blood flow distribution in Mas-deficient mice |
| Q26830036 | An evolving story of angiotensin-II-forming pathways in rodents and humans |
| Q37718893 | Ang (1-7) protects islet endothelial cells from palmitate-induced apoptosis by AKT, eNOS, p38 MAPK, and JNK pathways |
| Q35148155 | Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice. |
| Q34251889 | Angiotensin II-related hypertension and eye diseases |
| Q37120331 | Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research |
| Q55105269 | Angiotensin converting enzymes in patients with acute respiratory distress syndrome. |
| Q27022788 | Angiotensin peptides and nitric oxide in cardiovascular disease |
| Q51590953 | Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury. |
| Q53553738 | Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. |
| Q33554921 | Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate |
| Q34212176 | Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries |
| Q29347114 | Angiotensin-(1-7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons |
| Q38956473 | Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism |
| Q61813508 | Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction |
| Q46617665 | Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity |
| Q43198447 | Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats |
| Q36106355 | Angiotensin-(1-7) inhibits neuronal activity of dorsolateral periaqueductal gray via a nitric oxide pathway |
| Q35857448 | Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor |
| Q40524453 | Angiotensin-(1-7) protects from brain damage induced by shiga toxin 2-producing enterohemorrhagic Escherichia coli |
| Q45255856 | Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. |
| Q38569323 | Angiotensin-(1-7): beyond its central effects on blood pressure |
| Q36872082 | Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments |
| Q42908973 | Angiotensin-(1–7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: Role of MMPs/TIMPs |
| Q42554373 | Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease |
| Q38110281 | Angiotensin-II-derived reactive oxygen species on baroreflex sensitivity during hypertension: new perspectives. |
| Q34500735 | Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition |
| Q38207841 | Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets |
| Q36952795 | Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system |
| Q34115516 | Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells |
| Q40130425 | Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. |
| Q37155907 | Angiotensin-converting enzyme 2 in the brain: properties and future directions |
| Q37440125 | Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology |
| Q34978620 | Angiotensin-converting enzyme 2: central regulator for cardiovascular function |
| Q46061151 | Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. |
| Q37775515 | Arterial aging--hemodynamic changes and therapeutic options |
| Q51820362 | Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. |
| Q34150198 | Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7). |
| Q24337673 | Beneficial versus harmful effects of Angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart |
| Q33319072 | Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice |
| Q36902297 | Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen gene |
| Q40329899 | Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart |
| Q42204863 | Change in renin, cardiovascular and inflammatory markers over three years in a black and white population: the SABPA study. |
| Q35034941 | Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats |
| Q33881270 | Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats |
| Q46252912 | Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats |
| Q34065655 | Classical Renin-Angiotensin system in kidney physiology |
| Q92037515 | Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System |
| Q37592161 | Clinical perspectives and fundamental aspects of local cardiovascular and renal Renin-Angiotensin systems |
| Q39599579 | Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions |
| Q79901946 | Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese |
| Q86040157 | Correlativity between blood measures related to blood stasis blocking collaterals and gene expression of angiotensin-converting enzyme of renal cortex in diabetic rats and effect of stasis removing and collaterals dredging |
| Q37070124 | Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction |
| Q24650489 | Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome |
| Q107343965 | Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell–cell fusion |
| Q91862600 | Design, Synthesis, and Actions of an Innovative Bispecific Designer Peptide |
| Q38790937 | Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats |
| Q36877109 | Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension |
| Q48080337 | Differential expression of the angiotensin-(1-12)/chymase axis in human atrial tissue |
| Q37162551 | Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy. |
| Q41652967 | Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis |
| Q36836204 | Dose-dependent effects of angiotensin-(1-7) on the NHE3 exchanger and [Ca(2+)](i) in in vivo proximal tubules |
| Q33674294 | Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat. |
| Q44318194 | Effect of Telmisartan on local cardiovascular oxidative stress in mouse under chronic intermittent hypoxia condition |
| Q37167510 | Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil |
| Q40406847 | Effects of female sex hormones on expression of the Ang-(1-7)/Mas-R/nNOS pathways in rat brain |
| Q53691441 | Exercise Protects Against Defective Insulin Signaling and Insulin Resistance of Glucose Transport in Skeletal Muscle of Angiotensin II-Infused Rat. |
| Q54192199 | Expression of the Mas receptor is upregulated in skeletal muscle wasting. |
| Q34561377 | Gene expression, function and ischemia tolerance in male and female rat hearts after sub-toxic levels of angiotensin II. |
| Q80738386 | Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus |
| Q38948319 | Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension |
| Q48588159 | Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors |
| Q34049167 | Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection |
| Q37084921 | Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats |
| Q33655956 | Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed. |
| Q37580070 | Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction |
| Q36807942 | Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response |
| Q98774280 | Is Sex a Determinant of COVID-19 Infection? Truth or Myth? |
| Q39224534 | Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system |
| Q37192537 | Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. |
| Q91940739 | Liver-Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug-Resistant Gene 2-Knockout Mice |
| Q43152722 | Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2. |
| Q36938427 | Low glial angiotensinogen improves body habitus, diastolic function, and exercise tolerance in aging male rats. |
| Q37147841 | New angiotensins |
| Q37730859 | New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy. |
| Q37660786 | New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism |
| Q61920272 | Nicotine and the renin-angiotensin system |
| Q35859762 | Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target |
| Q45276776 | Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects |
| Q98197535 | Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension |
| Q28279771 | Physiology of kidney renin |
| Q93119593 | Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease |
| Q37078949 | Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly |
| Q37264506 | Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2. |
| Q90566958 | Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |
| Q37551225 | Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme |
| Q91868876 | Rapeseed protein-derived peptides, LY, RALP, and GHS, modulates key enzymes and intermediate products of renin-angiotensin system pathway in spontaneously hypertensive rat |
| Q36013823 | Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control |
| Q90576869 | Renin-angiotensin system in human coronavirus pathogenesis |
| Q35931751 | Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review |
| Q44817032 | Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling |
| Q38315620 | Role of angiotensin-(1-7) and Mas-R-nNOS pathways in amplified neuronal activity of dorsolateral periaqueductal gray after chronic heart failure |
| Q34139061 | Role of olmesartan in combination therapy in blood pressure control and vascular function |
| Q26747017 | Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension |
| Q55363090 | Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension. |
| Q36175799 | Role of upstream stimulatory factor 2 in diabetic nephropathy |
| Q50573929 | Sex-Specific Changes in Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression and Enzyme Activity at Birth and Over the First Year of Life. |
| Q30440362 | Should we employ combination ACEI and ARB therapy in primary hypertension? |
| Q57117619 | Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression |
| Q37139937 | Targeting tissue angiotensin-converting enzyme for imaging cardiopulmonary fibrosis |
| Q55508970 | Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity. |
| Q37955284 | Telmisartan: just an antihypertensive agent? A literature review |
| Q24633556 | The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function |
| Q46924901 | The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle. |
| Q38560678 | The Dermatological Manifestations of Postural Tachycardia Syndrome: A Review with Illustrated Cases |
| Q54189352 | The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice. |
| Q26823573 | The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges |
| Q51010079 | The effects of angiotensin-(1-7) on the exchanger NHE3 and on [Ca2+]i in the proximal tubules of spontaneously hypertensive rats. |
| Q36804138 | The emerging role of ACE2 in physiology and disease |
| Q43225779 | The mechanism of distinct diurnal variations of renin-angiotensin system in aorta and heart of spontaneously hypertensive rats |
| Q48248287 | The phosphoinositide-3 kinase signaling is involved in neuroinflammation in hypertensive rats. |
| Q36790149 | The role and regulation of cardiac angiotensin-converting enzyme for noninvasive molecular imaging in heart failure |
| Q28575188 | The role of angiotensin-(1-7) receptor Mas in spermatogenesis in mice and rats |
| Q53554689 | Therapeutic drugs during healing after myocardial infarction modify infarct collagens and ventricular distensibility at elevated pressures. |
| Q37505732 | Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis |
| Q33677369 | Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases |
| Q36769062 | Therapeutic potential of targeting the renin angiotensin system in portal hypertension. |
| Q80390701 | Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis |
| Q35813377 | Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity. |
| Q36744015 | Valsartan in the treatment of heart attack survivors |
Search more.